Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
In 2021 alone, the FDA cataloged over 100,000 adverse reactions from users of Ozempic and related semaglutide drugs
By doing so, it can significantly reduce hunger, which helps in controlling calorie intake and managing weight effectively
They found liraglutide increased testosterone, luteinizing hormone and follicle-stimulating hormone levels, while semaglutide improved sperm morphology
Unlike earlier-generation weight-management agents, retatrutide is a triple receptor agonist , meaning it simultaneously activates three distinct hormonal receptors: GLP-1 (glucagon-like peptide-1) receptor promotes insulin secretion, reduces appetite, and slows gastric emptying [9] [10] GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin release and may improve fat metabolism [12] [13] Glucagon receptor increases energy expenditure and may reduce hepatic steatosis, as suggested by imaging data (MRI-PDFF) from Phase 2 trials, though this effect requires confirmation in larger studies [2] [5] This triple-agonist mechanism distinguishes retatrutide from agents such as semaglutide (GLP-1 only) or tirzepatide (GLP-1/GIP dual agonist), and is thought to produce more pronounced reductions in body weight and improvements in metabolic parameters
US$ 27.40
US$ 28.10
US$ 29.78
